Semaglutide/Glycine/B12 Program

Not available for residents of Alaska, California, Indiana, Michigan, Minnesota, New Mexico, Oregon, Rhode Island, South Carolina (please contact us for alternative options)

Semaglutide + Glycine + B12 — Strive Pharmacy Blend

At Invyncible, our providers offer access to semaglutide through structured treatment programs. These programs are organized to reflect common treatment patterns that many patients are already familiar with. This makes it easier for patients transitioning from other providers or pharmacies to continue in a way that feels consistent and understandable.

We do not compound or dispense medications. Prescriptions are reviewed during your intake process and filled by independent, licensed compounding pharmacies.

Our program options are structured to mirror familiar dosing patterns rather than leaving patients uncertain about how to begin or continue treatment.

• Starter: Designed for patients new to semaglutide who are beginning at introductory levels.
• Maintenance: For those who have already adjusted and are continuing long-term therapy.
• Programs 1–3: Reflect common ongoing dosing patterns patients may have followed with other providers.

These programs exist to provide clarity and continuity, not to replace medical judgment. All prescriptions are reviewed during the intake process before being sent to a pharmacy.

Semaglutide is a GLP-1 receptor agonist originally FDA-approved for chronic weight management. It works by slowing digestion, helping regulate appetite, and supporting healthier eating patterns. In compounded form, Strive Pharmacy includes vitamin B12 and glycine alongside semaglutide. Some patients and providers prefer this combination for support with tolerability.

This semaglutide + glycine + B12 blend is prepared by Strive Pharmacy, an independent licensed compounding pharmacy. Patients may request a different pharmacy. If you prefer another pharmacy, please indicate this on your clinical intake form so our team can accommodate your request.

Your Care Journey

Accessing semaglutide with glycine and vitamin B12 through Invyncible is designed to be straightforward and provider-led:

1. Secure Your Intake – Submit your health history and treatment goals through our private intake system.

2. Licensed Provider Review – A provider will connect with you to review your information, answer any questions, and determine if this Strive Pharmacy blend is appropriate.

3. Prescription Processing – If approved, your prescription is coordinated with Strive Pharmacy, or with another licensed compounding pharmacy if preferred.

4. Treatment Access – Your program begins with clear instructions based on your provider’s guidance.

5. Continued Care – Providers remain available for check-ins, progress updates, and support throughout your treatment.

Potential Side-Effects

Invyncible is a telemedicine provider network, not a pharmacy. We do not compound medications. Side-effect information is provided for educational purposes and is based on documentation published by Strive Pharmacy and general clinical literature.

• Common side-effects may include nausea, vomiting, diarrhea, constipation, stomach pain, acid reflux, or injection site reactions.
• Less common but more serious risks may include pancreatitis, gallbladder disease, or thyroid-related outcomes.
• Compounded medications may carry additional risks, including variability in formulation and measurement differences, as noted by the FDA.

This is not a complete list. Please review the pharmacy’s full documentation and consult your provider before starting treatment.

What We Do

• Provide telemedicine consultations with licensed providers
• Offer structured treatment programs for patients familiar with semaglutide
• Coordinate with pharmacies to ensure prescriptions are filled

What We Don’t Do

• We are not a pharmacy
• We do not compound medications
• We do not sell medications directly

Important Safety Information

This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Before beginning any new treatment, especially if you have underlying health issues, are taking prescription medications, or if you are pregnant or breastfeeding, consult with a licensed healthcare provider.

Compounded Use Statement

Compounded versions of semaglutide are not FDA-approved. Neither the FDA nor any other regulatory agency has reviewed these products for safety, quality, or effectiveness.

FDA-Approved Alternative

An FDA-approved version of semaglutide, marketed under the brand name Wegovy®, is also available. Your provider will determine whether an FDA-approved product or a compounded option is appropriate for you.

Disclaimer

Invyncible is a telemedicine provider network. Prescriptions are reviewed by licensed providers and filled by independent compounding pharmacies or commercial manufacturers. Availability may vary by state and pharmacy.

All prescriptions require provider review and approval. The listed options are structured programs, not self-selected doses.